Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice

Author： Dunn L.A.   McMillan D.J.   Batzloff M.   Zeng W.   Jackson D.C.J.   Upcroft J.A.   Upcroft P.   Olive C.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.21, 2002-06, pp. : 2635-2640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

By Dale J.B.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 193-200

Elsevier

Access to resources Recommend Favorite

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

By Olive C.   Clair T.   Yarwood P.   Good M.F.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2816-2825

Elsevier

Access to resources Recommend Favorite

Recombinant, octavalent group A streptococcal M protein vaccine

By Dale J.B.   Simmons M.   Chiang E.C.   Chiang E.Y.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults

By Kotloff K.L.   Fattom A.   Basham L.   Hawwari A.   Harkonen S.   Edelman R.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 446-450

Elsevier

Access to resources Recommend Favorite

Mucosal vaccine delivery: is M cell-targeted delivery effective in the mucosal lumen?

By Lo David D  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 2, 2013-02 ,pp. : 157-161

Informa Healthcare

Access to resources Recommend Favorite